Modulation of platelet adhesion based on the surface-exposed beta-switch loop of platelet glycoprotein IB-alpha
    3.
    发明授权
    Modulation of platelet adhesion based on the surface-exposed beta-switch loop of platelet glycoprotein IB-alpha 有权
    基于血小板糖蛋白IB-α的表面暴露β-开关环调节血小板粘附

    公开(公告)号:US07771724B2

    公开(公告)日:2010-08-10

    申请号:US11053199

    申请日:2005-02-07

    IPC分类号: A61K39/395

    摘要: The invention relates to the adhesion of platelet GpIbα to strand β3 of domain A1 of von Willebrand factor (vWF), the strand β3 comprising amino acid residues at amino acid position 560-566 and/or a functional part or equivalent thereof, the platelet GpIbα, the GpIbα region comprising an amino acid sequence corresponding to a beta-switch loop of platelet GpIbα, comprising amino acid residues at amino acid position 227-242 and/or a functional part or equivalent thereof. The invention provides a method of interfering with adhesion of blood platelets to vWF that includes modulating adhesion. The invention further provides proteinaceous compounds, antibodies, medicaments and pharmaceutical compositions to that end. The invention also provides means and methods to increase platelet adhesion by topical application of a compound increasing platelet adhesion.

    摘要翻译: 本发明涉及血小板GpIbα对血管性血友病因子(vWF)的结构域A1的链和结合域3的粘附,其中包含在氨基酸位置560-566处的氨基酸残基的链&bgr 3和/或其功能部分或等同物 ,血小板GpIbα,GpIbα区域包含对应于血小板GpIbα的β-切换环的氨基酸序列,其包含氨基酸位置227-242的氨基酸残基和/或其功能部分或等同物。 本发明提供了一种干扰血小板粘附到包括调节粘附的vWF的方法。 本发明进一步提供蛋白质化合物,抗体,药物和药物组合物。 本发明还提供了通过局部施用增加血小板粘附的化合物来增加血小板粘附的方法和方法。

    Modulation platelet adhesion based on the surface-exposed beta-switch loop of platelet glycoprotein IB-alpha
    4.
    发明申请
    Modulation platelet adhesion based on the surface-exposed beta-switch loop of platelet glycoprotein IB-alpha 有权
    基于血小板糖蛋白IB-α的表面暴露β-开关环调节血小板粘附

    公开(公告)号:US20050192224A1

    公开(公告)日:2005-09-01

    申请号:US11053199

    申请日:2005-02-07

    摘要: The invention relates to the adhesion of platelet GpIbα to strand β3 of domain A1 of von Willebrand factor (vWF), the strand β3 comprising amino acid residues at amino acid position 560-566 and/or a functional part or equivalent thereof, the platelet GpIbα, the GpIbα region comprising an amino acid sequence corresponding to a beta-switch loop of platelet GpIbα, comprising amino acid residues at amino acid position 227-242 and/or a functional part or equivalent thereof. The invention provides a method of interfering with adhesion of blood platelets to vWF that includes modulating adhesion. The invention further provides proteinaceous compounds, antibodies, medicaments and pharmaceutical compositions to that end. The invention also provides means and methods to increase platelet adhesion by topical application of a compound increasing platelet adhesion.

    摘要翻译: 本发明涉及血小板GpIbalpha与血管性血友病因子(vWF)的结构域A1的链β3的粘附,包含氨基酸位置560-566处氨基酸残基的链β3和/或其功能部分或等同物,血小板GpIbalpha GpIbalpha区包含对应于血小板GpIbalpha的β-切换环的氨基酸序列,其包含氨基酸位置227-242处的氨基酸残基和/或其功能部分或等同物。 本发明提供了一种干扰血小板粘附到包括调节粘附的vWF的方法。 本发明进一步提供蛋白质化合物,抗体,药物和药物组合物。 本发明还提供了通过局部施用增加血小板粘附的化合物来增加血小板粘附的方法和方法。